Use of inhaled epoprostenol in transition to extubation in a patient after implantation of a ventricular assist device.
Shapiro
Mark
M
Department of Surgery, Mount Siani School of Medicine, New York, NY 10029, USA.
Scurlock
Corey
C
Raikhelkar
Jayashree
J
Weiss
Aaron
A
Anyanwu
Anelechi
A
Schachter
E Neil
EN
D000280:Administration, Inhalation; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006328:Cardiac Catheterization; D006348:Cardiac Surgical Procedures; D011464:Epoprostenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017809:Fatal Outcome; D006333:Heart Failure / Q000601:surgery; D006353:Heart-Assist Devices; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007442:Intubation, Intratracheal; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy*; D019919:Prosthesis Implantation; D014139:Tracheostomy; D018754:Ventricular Dysfunction / Q000150:complications / Q000628:therapy
D000959:Antihypertensive Agents; D011464:Epoprostenol